Janelle Hart
Articles
Adjuvant Mitotane Misses RFS End Point in Adrenocortical Carcinoma
February 27, 2022
Article
Adjuvant mitotane did not yield a significantly reduced risk of recurrence among patients with adrenocortical carcinoma.
Advertisement
Advertisement